| scholarly article | Q13442814 |
| P2093 | author name string | Yang Xia | |
| Roxanna A Irani | |||
| P2860 | cites work | Regional flow-pressure relationship in response to angiotensin in the intact dog and sheep | Q78778708 |
| Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences | Q79260245 | ||
| Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation | Q79760387 | ||
| Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia? | Q80316215 | ||
| Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension | Q80361560 | ||
| Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia | Q82705098 | ||
| Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor | Q24320710 | ||
| Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. | Q24537348 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Endothelin 1 and angiotensin II in preeeclampsia | Q28306251 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney | Q30471269 | ||
| Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo | Q31404999 | ||
| The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia | Q33591058 | ||
| Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia | Q33748650 | ||
| Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
| Oxidative stress in the pathogenesis of preeclampsia | Q33796834 | ||
| Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? | Q33811293 | ||
| The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis | Q33838726 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study | Q33947553 | ||
| Structure and function of VEGF/VEGF-receptor system involved in angiogenesis | Q34246910 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
| Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
| Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study | Q34950435 | ||
| Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia | Q35079406 | ||
| Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
| AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia | Q35689550 | ||
| Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome | Q35750283 | ||
| Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis | Q35763556 | ||
| Genetic progress towards the molecular basis of autoimmunity. | Q36368037 | ||
| Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia | Q36524450 | ||
| The immune system and happiness. | Q36617511 | ||
| Physiologic changes in pregnancy | Q37125168 | ||
| Control of vascular responsiveness during human pregnancy | Q40122647 | ||
| The uteroplacental renin-angiotensin system: a review | Q40652280 | ||
| Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation | Q40735093 | ||
| Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors. | Q40867054 | ||
| Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia | Q41068505 | ||
| Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence | Q41098649 | ||
| Preeclampsia: an endothelial cell disorder | Q41281924 | ||
| Postpartum renal lesions in women with pre-eclampsia | Q41682946 | ||
| Sodium excretion in normal and hypertensive pregnancy: a prospective study | Q41976105 | ||
| Lymphocyte intracellular free calcium concentration is increased in preeclampsia | Q42472176 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage | Q44550393 | ||
| AT1b receptor predominantly mediates contractions in major mouse blood vessels | Q44620902 | ||
| Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
| Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women | Q46136176 | ||
| Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia | Q46305789 | ||
| Impaired placental neovascularization in mice with pregnancy-associated hypertension | Q46337204 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Agonistic AT1 receptor autoantibodies and monocyte stimulation in hypertensive patients*1 | Q47447775 | ||
| Endothelial dysfunction in preeclampsia | Q47879591 | ||
| The human placental renin-angiotensin system | Q48430627 | ||
| Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. | Q51942463 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| Physiological and pharmacological implications of AT1 versus AT2 receptors. | Q54125354 | ||
| Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births | Q61847698 | ||
| Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy | Q67321033 | ||
| Morphometric analysis of pre-eclampsia in women biopsied in pregnancy and post-partum | Q67982464 | ||
| Renin-aldosterone relationships in pregnancy-induced hypertension | Q68044331 | ||
| Immunofluorescent Studies in Renal Biopsies in Pre-eclampsia | Q69331622 | ||
| Erythrocyte cation metabolism in preeclampsia | Q69354420 | ||
| Angiotensin-Converting Enzyme and the Renin-Angiotensin System in Normotensive Primigravid Pregnancy | Q70152788 | ||
| Changes in active and inactive renin throughout pregnancy | Q70219673 | ||
| Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR | Q71530460 | ||
| Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells | Q71645969 | ||
| Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen | Q71695937 | ||
| A prospective study of plasma angiotensin-converting enzyme in normotensive primigravidae and their infants | Q72914158 | ||
| Immunocytochemistry of the renin-angiotensin system: renin, angiotensinogen, angiotensin I, angiotensin II, and converting enzyme in the kidneys of mice, rats, and tree shrews | Q72960641 | ||
| Calcium metabolism in pre-eclampsia | Q73225217 | ||
| Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation | Q73317060 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia | Q74195115 | ||
| Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia | Q74527090 | ||
| An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation | Q75197234 | ||
| Induction of urokinase receptor expression in nephrotoxic nephritis | Q77149613 | ||
| Pregnancy-induced changes in renin gene expression in mice | Q77372149 | ||
| Microalbuminuria after pregnancy complicated by pre-eclampsia | Q77799245 | ||
| Angiotensin-(1-7) can interact with the rat proximal tubule AT(4) receptor system | Q78009526 | ||
| Angiotensin-(1-7) in normal and preeclamptic pregnancy | Q78568866 | ||
| Pressor response to angiotonin in pregnant and nonpregnant women | Q78762451 | ||
| P433 | issue | 1 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| maternal health | Q6786626 | ||
| P304 | page(s) | 47-58 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Seminars in Nephrology | Q15761561 |
| P1476 | title | Renin angiotensin signaling in normal pregnancy and preeclampsia | |
| P478 | volume | 31 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q38126570 | A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery |
| Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
| Q34040304 | Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia |
| Q86418101 | Asian women have attenuated sympathetic activation but enhanced renal-adrenal responses during pregnancy compared to Caucasian women |
| Q50018363 | Associations of the dietary approaches to stop hypertension (DASH) diet with pregnancy complications in Project Viva |
| Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
| Q47546219 | Contribution of angiotensinogen M235T and T174M gene variants and haplotypes to preeclampsia and its severity in (North African) Tunisians |
| Q88868647 | Developmental origins of pregnancy-induced cardiac changes: establishment of a novel model using the atrial natriuretic peptide gene-disrupted mice |
| Q60930825 | Effects of multiparity on left ventricular diastolic dysfunction in women: cross-sectional study of the KoRean wOmen'S chest pain rEgistry (KoROSE) |
| Q93008915 | Evidence of Augmented Intrarenal Angiotensinogen Associated With Glomerular Swelling in Gestational Hypertension and Preeclampsia: Clinical Implications |
| Q61632353 | Gestational Geophagia Affects Nephrocardiac Integrity, ATP-Driven Proton Pumps, the Renin–Angiotensin–Aldosterone System, and F2-Isoprostane Status |
| Q33581546 | Gestational protein restriction increases angiotensin II production in rat lung |
| Q26997104 | Hormones and hemodynamics in pregnancy |
| Q46638900 | Human placental renin-angiotensin system in normotensive and pre-eclamptic pregnancies at high altitude and after acute hypoxia-reoxygenation insult. |
| Q47749827 | Icariin improves acute kidney injury and proteinuria in a rat model of pregnancy‑induced hypertension |
| Q50672696 | Indoleamine 2,3-dioxygenase (IDO) activity in placental compartments of renal-transplanted pregnant women. |
| Q93090791 | Kidney microRNA profile in pregnant mice reveals molecular insights into kidney adaptation to pregnancy: A pilot study |
| Q47581048 | Long-term presence of angiotensin II type 1 receptor autoantibody reduces aldosterone production by triggering Ca(2+) overload in H295R cells |
| Q40356250 | Onset and Regression of Pregnancy-Induced Cardiac Alterations in Gestationally Hypertensive Mice: The Role of the Natriuretic Peptide System |
| Q38017497 | Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome |
| Q26865332 | Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology |
| Q26746794 | Physiological changes in pregnancy |
| Q36907975 | Placental Vacuolar ATPase Function Is a Key Link between Multiple Causes of Preeclampsia |
| Q34506462 | Protein profiling of preeclampsia placental tissues |
| Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
| Q36047164 | Regulation of the Renin-Angiotensin System Pathways in the Human Decidua. |
| Q33411571 | Renal function in normal and disordered pregnancy |
| Q33871523 | Renal physiology of pregnancy |
| Q83277636 | Role of renin-angiotensin system and oxidative status on the maternal cardiovascular regulation in spontaneously hypertensive rats |
Search more.